Biomarkers and Novel Therapeutic Targets to Personalize Cancer Care

We are interested in dissecting molecular mechanisms of tumor cell resistance to cancer therapies such as radiation in order to develop novel therapies to improve outcomes for patients diagnosed with cancer.

The lab has a specific interest in the role of serine protease inhibitor (SERPIN) superfamily of proteins and the lysosome in tumor cell response to ionizing radiation in cervical cancer.